Cash and Cash Equivalents

-11.9%

The decline from 12,792k to 11,275k reflects increased cash outflows for property and equipment purchases as well as principal payments on long‑term debt that followed prior period financing activities. Previous period actions like borrowing and capital contributions helped boost the balance, but subsequent investments and repayments reversed part of that gain. " "

Restricted Cash

+4300%+

The jump from 250k to 11,275k suggests a major reallocation or earmarking of funds, likely driven by new regulatory requirements or collateral arrangements linked to debt financing and acquisitions. The minimal allocation in the previous period contrasts sharply with the current period as the company meets new funding conditions. " "

Total Current Assets

+22.8%

An increase from 21,365k to 26,258k is primarily driven by higher accounts receivable and other receivables, reflecting increased revenues and delayed collections. This growth builds on earlier period trends where rising customer receivables and added prepaid items already started to boost the current asset base. " "

Total Assets

+20.1%

Expansion from 50,124k to 60,197k is largely attributable to strategic investments such as the acquisition of radiation therapy centers and new facility expansions that increased property, plant, and equipment values. Prior period investments laid the groundwork, and continued capital deployment further boosted total assets. " "

Total Equity

+10.4%

Growth from 22,841k to 25,183k is driven by a significant increase in net income (including a 258.4% rise and a bargain purchase gain) and contributions from stock-based compensation and non‑controlling interests. This builds upon improvements in operational performance and retention of earnings seen in previous periods. " "